- Filed
- Dec 15, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2022 · Oct 31, 2021 | 779.87M sh |
| Capex | Q2 2022 · Oct 31, 2021 | $189.13K |
| Capex | Q2 2022 · Oct 31, 2020 | $0 |
| Operating Cash Flow | Q2 2022 · Oct 31, 2021 | $261.27K |
| Operating Cash Flow | Q2 2022 · Oct 31, 2020 | $80.79K |
| Cash And Equivalents | Q2 2022 · Oct 31, 2021 | $2.19K |
| Cash And Equivalents | Q2 2022 · Apr 30, 2021 | $1.94K |
| Cash And Equivalents | Q2 2022 · Oct 31, 2020 | $1.24K |
| Cash And Equivalents | Q2 2022 · Apr 30, 2020 | $24.7K |
| Stockholders Equity | Q2 2022 · Oct 31, 2021 | $6.44M |
| Stockholders Equity | Q2 2022 · Apr 30, 2021 | $6.17M |
| Current Liabilities | Q2 2022 · Oct 31, 2021 | $542.5K |
| Current Liabilities | Q2 2022 · Apr 30, 2021 | $614.88K |
| Total Liabilities | Q2 2022 · Oct 31, 2021 | $542.5K |
| Total Liabilities | Q2 2022 · Apr 30, 2021 | $614.88K |
| Current Assets | Q2 2022 · Oct 31, 2021 | $1.26M |
| Current Assets | Q2 2022 · Apr 30, 2021 | $1.25M |
| Total Assets | Q2 2022 · Oct 31, 2021 | $6.98M |
| Total Assets | Q2 2022 · Apr 30, 2021 | $6.79M |
| Sga Expense | Q2 2022 · Oct 31, 2021 | $15.91K |
| Sga Expense | Q2 2022 · Oct 31, 2021 | $20.25K |
| Sga Expense | Q2 2022 · Oct 31, 2020 | $2.86K |
| Sga Expense | Q2 2022 · Oct 31, 2020 | $7.91K |
| Net Income | Q2 2022 · Oct 31, 2021 | $5.81K |
| Net Income | Q2 2022 · Oct 31, 2021 | −$45.99K |
| Net Income | Q2 2022 · Oct 31, 2020 | −$50.07K |
| Net Income restated | Q2 2022 · Oct 31, 2020 | $57.2M |
| Operating Income | Q2 2022 · Oct 31, 2021 | −$27.41K |
| Operating Income | Q2 2022 · Oct 31, 2021 | −$350.65K |
| Operating Income | Q2 2022 · Oct 31, 2020 | −$56.73K |
| Operating Income | Q2 2022 · Oct 31, 2020 | −$3.84M |